Carregant...
Cancer symptom response as an oncology clinical trial end point
INTRODUCTION: A critical challenge in oncology is interpreting clinical trial results to inform clinical decision making. Clinical trials typically focus on overall survival (OS) and progression-free survival (PFS) as primary endpoints, which do not reflect early signs of meaningful patient benefit...
Guardat en:
| Publicat a: | Expert Rev Qual Life Cancer Care |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476191/ https://ncbi.nlm.nih.gov/pubmed/31020045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23809000.2018.1483193 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|